NDC 42291-904 – Sunitinib Malate
Sunitinib Malate 50 mg/1 · Capsule · Oral
Product NDC42291-904
Product details
- Brand name
- Sunitinib Malate
- Generic name
- Sunitinib Malate
- Labeler
- AvKARE
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA213803
- Marketed since
- October 11, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Sunitinib Malate 50 mg/1
Uses, dosage, side effects and warnings for Sunitinib Malate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42291-904-28 | 28 CAPSULE in 1 BOTTLE (42291-904-28) | Oct 11, 2023 |
Recalls mentioning this NDC
- D-0104-2025 Dec 11, 2024 · Class II
Labeling: Label Mix-Up - D-0103-2025 Dec 11, 2024 · Class II
Labeling: Label Mix-Up
Other Sunitinib Malate products
- 59651-467 Sunitinib Malate 50 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-466 Sunitinib Malate 37.5 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-464 Sunitinib Malate 12.5 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-465 Sunitinib Malate 25 mg/1 · Capsule · Aurobindo Pharma Limited
- 42291-903 Sunitinib Malate 37.5 mg/1 · Capsule · AvKARE
- 42291-902 Sunitinib Malate 25 mg/1 · Capsule · AvKARE
- 42291-901 Sunitinib Malate 12.5 mg/1 · Capsule · AvKARE
- 43598-045 Sunitinib Malate 12.5 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 43598-046 Sunitinib Malate 25 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 43598-047 Sunitinib Malate 37.5 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 43598-048 Sunitinib Malate 50 mg/1 · Capsule · Dr.Reddys Laboratories Inc
- 0378-6680 Sunitinib Malate 50 mg/1 · Capsule · Mylan Pharmaceuticals Inc.